- 4-Week # shares bought: 4,000
- 4-Week # shares sold: 345,043
- 12-Week # shares bought: 19,000
- 12-Week # shares sold: 384,339
- 24-Week # shares bought: 24,000
- 24-Week # shares sold: 525,517
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
Trade-Ideas LLC identified C.R. Bard (BCR) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate